Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H14N3O5S2.Na |
| Molecular Weight | 391.398 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC(=O)[N-]S(=O)(=O)C1=CC(N)=CC=C1S(=O)(=O)C2=CC=C(N)C=C2
InChI
InChIKey=PVGBHEUCHKGFQP-UHFFFAOYSA-M
InChI=1S/C14H15N3O5S2.Na/c1-9(18)17-24(21,22)14-8-11(16)4-7-13(14)23(19,20)12-5-2-10(15)3-6-12;/h2-8H,15-16H2,1H3,(H,17,18);/q;+1/p-1
Acetosulfone (promacetin®) (sodium 4,4′-diaminodiphenylsulfone-2-acetylsulfonamide) is much less toxic sulfone than sulfoxone sodium (diasone®). Acetosulfone is an antibacterial agent. It has been used in the treatment of leprosy, has been under study in the Department of Dermatology at the University of Cincinnati College of Medicine since 1949. Acetosulfone was also used for the treatment of sarcoidosis. It was tested in the treatment of the Duhring's disease.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13346157
Dermatitis herpetiformis: Daily dose of three grams for a maintenance dose
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C849
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
128-12-1
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
11954271
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
DTXSID7022548
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
m543
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB10694MIG
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
1971
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
C76986
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
107528
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL3306903
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
100000083264
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY | |||
|
FQ3M2Y4BU3
Created by
admin on Mon Mar 31 17:47:34 GMT 2025 , Edited by admin on Mon Mar 31 17:47:34 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD